门诊肩部手术中持续术后阿片类药物处方配药与周围神经阻滞:回顾性队列研究
该回顾性队列研究纳入加拿大安大略省2012至2017年接受门诊肩部手术的48,523例患者,旨在探讨周围神经阻滞与持续术后阿片类药物处方配药的关系。结果显示,接受神经阻滞的患者持续配药发生率为16%,未接受者为18%(调整OR 0.90,95%CI 0.83-0.97,P=0.007),但该关联在倾向性评分匹配等敏感性分析中未重现。结论认为神经阻滞与持续术后阿片类药物配药发生率降低无关。
要点
- 接受周围神经阻滞者持续术后阿片处方配药率为16%,未接受者为18%。
- 多因素分析显示神经阻滞与持续配药降低相关(OR 0.90),但敏感性分析未证实。
- 门诊肩部手术中,神经阻滞未显著降低持续术后阿片类药物配药风险。
核心结论
- 在门诊肩部手术患者中,周围神经阻滞与持续术后阿片类药物处方配药发生率降低无关。
研究设计与样本
- 回顾性基于人群的队列研究,纳入加拿大安大略省2012年7月1日至2017年12月31日接受择期肩部手术的患者48,523例,来自118家医院。
主要发现
- 8,229例(17%)患者存在持续术后阿片类药物处方配药。
- 接受周围神经阻滞者中5,008例(16%)出现持续配药,未接受者为3,221例(18%),调整OR 0.90(95%CI 0.83-0.97,P=0.007)。
- 在粗化精确匹配敏感性分析中,调整OR 0.85(95%CI 0.71-1.02,P=0.087),关联无统计学显著性。
关键数值与推荐
- 阿片初治患者:术后90至365天期间配药至少60天供应量定义为持续配药。
- 阿片暴露患者(术前90天内日剂量<60 mg口服吗啡当量)或阿片耐受患者(日剂量≥60 mg口服吗啡当量):术后90至365天期间配药量较术前基线增加定义为持续配药。
临床怎么用
- 对于门诊肩部手术患者,不应仅依赖周围神经阻滞来降低持续术后阿片类药物配药风险。
局限性
- 回顾性研究设计可能受混杂因素影响,主要关联在敏感性及亚组分析中未重现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is need to identify perioperative interventions that decrease chronic opioid use. The authors hypothesized that receipt of a peripheral nerve block would be associated with a lower incidence of persistent postoperative opioid prescription fulfillment. METHODS: This was a retrospective population-based cohort study examining ambulatory shoulder surgery patients in Ontario, Canada. The main outcome measure was persistent postoperative opioid prescription fulfillment. In opioid-naive patients (no opioid prescription fulfillment in 90 days preoperatively), this was present if an individual fulfilled an opioid prescription of at least a 60-day supply during postoperative days 90 to 365. In opioid-exposed (less than 60 mg oral morphine equivalent dose per day within 90 days preoperatively) or opioid-tolerant (60 mg oral morphine equivalent dose per day or above within 90 days preoperatively) patients, this was classified as present if an individual experienced any increase in opioid prescription fulfillment from postoperative day 90 to 365 relative to their baseline use before surgery. The authors' exposure was the receipt of a peripheral nerve block. RESULTS: The authors identified 48,523 people who underwent elective shoulder surgery from July 1, 2012, to December 31, 2017, at one of 118 Ontario hospitals. There were 8,229 (17%) patients who had persistent postoperative opioid prescription fulfillment. Of those who received a peripheral nerve block, 5,008 (16%) went on to persistent postoperative opioid prescription fulfillment compared to 3,221 (18%) patients who did not (adjusted odds ratio, 0.90; 95% CI, 0.83 to 0.97; P = 0.007). This statistically significant observation was not reproduced in a coarsened exact matching sensitivity analysis (adjusted odds ratio, 0.85; 95% CI, 0.71 to 1.02; P = 0.087) or several other subgroup and sensitivity analyses. CONCLUSIONS: This retrospective analysis found no association between receipt of a peripheral nerve block and a lower incidence of persistent postoperative opioid prescription fulfillment in ambulatory shoulder surgery patients.
引用
- Hamilton GM, Tierney S, Ramlogan R, et al. Persistent Postoperative Opioid Prescription Fulfillment and Peripheral Nerve Blocks for Ambulatory Shoulder Surgery: A Retrospective Cohort Study. Anesthesiology. 2021. PMID: 34525173. doi:10.1097/ALN.0000000000003962
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。